Sanatela Medical
Sanatela Medical is dedicated to advancing medical technologies by developing and commercializing innovative biomaterials and regenerative solutions. Their flagship product, the Sanatela TM Matrix, is an advanced biomaterial designed for cancer treatment screening, tissue regeneration, and wound care. The company focuses on personalized medicine, regenerative medicine, and high-throughput drug screening, aiming to improve treatment efficacy and patient outcomes through cutting-edge research and partnerships.
Industries
Nr. of Employees
small (1-50)
Sanatela Medical
Rochester, New York, United States, North America
Products
Decellularized Wharton's Jelly scaffold (research format)
Porous, lyophilized extracellular-matrix scaffold derived from human umbilical cord Wharton's Jelly, supplied in laboratory-friendly formats (e.g., disk segments, sheets, multi-well plate formats) for in vitro cell culture and drug screening.
Research-grade ancillary biomaterials and supplements
A pipeline of research materials including viable Wharton's Jelly tissue, Wharton's Jelly–derived stem cells, culture media and supplements, decellularized felts/foams/matrix variants, mineralized matrix variants and regenerative hemostat formulations for in vitro and in vivo research.
Sanatela Matrix
An advanced biomaterial tissue made from decellularized and bioengineered Wharton's jelly from human umbilical cords, designed to attract, isolate, and culture cancer cells for drug screening and individualized therapy.
Stem Cell 3D Niche
A 3D cell culture niche product utilizing the Matrix for stem cell and cancer research applications.
Wound Dressing
A wound and burn dressing made from the Matrix material designed to never need removal and help the body regenerate skin tissue without leaving a scar.
Bone Void Filler
A clinical product designed for bone regeneration to fill fractures or defects with viable tissue that mineralizes into living bone.
Decellularized Wharton's Jelly scaffold (research format)
Porous, lyophilized extracellular-matrix scaffold derived from human umbilical cord Wharton's Jelly, supplied in laboratory-friendly formats (e.g., disk segments, sheets, multi-well plate formats) for in vitro cell culture and drug screening.
Research-grade ancillary biomaterials and supplements
A pipeline of research materials including viable Wharton's Jelly tissue, Wharton's Jelly–derived stem cells, culture media and supplements, decellularized felts/foams/matrix variants, mineralized matrix variants and regenerative hemostat formulations for in vitro and in vivo research.
Sanatela Matrix
An advanced biomaterial tissue made from decellularized and bioengineered Wharton's jelly from human umbilical cords, designed to attract, isolate, and culture cancer cells for drug screening and individualized therapy.
Stem Cell 3D Niche
A 3D cell culture niche product utilizing the Matrix for stem cell and cancer research applications.
Wound Dressing
A wound and burn dressing made from the Matrix material designed to never need removal and help the body regenerate skin tissue without leaving a scar.
Bone Void Filler
A clinical product designed for bone regeneration to fill fractures or defects with viable tissue that mineralizes into living bone.
Services
Provision of scaffold kits and collaborative research projects enabling external investigators to evaluate scaffold applications in oncology, stem cell and regenerative-medicine studies.
Pre-order availability of scaffold sheets and test kits for select research hospitals, cancer and stem cell centers and high-throughput drug testing firms prior to broader commercial release.
Provision of scaffold kits and collaborative research projects enabling external investigators to evaluate scaffold applications in oncology, stem cell and regenerative-medicine studies.
Pre-order availability of scaffold sheets and test kits for select research hospitals, cancer and stem cell centers and high-throughput drug testing firms prior to broader commercial release.
Expertise Areas
- Biomaterial scaffold development
- Cancer stem cell in vitro modeling
- Personalized ex vivo drug screening
- Regenerative medicine product development (wound, bone, skin)
Key Technologies
- Decellularized extracellular matrix scaffolds
- 3D cell-culture platforms
- High-throughput screening formats (multi-well compatible)
- Lyophilization of biomaterials
News & Updates
Upcoming Events – Fall 2019
Sanatela Medical will attend various conferences including Resi Conference, CNY Biotech Accelerator, NYS Innovation Summit, Medtech 2019, Start Up Summit, and RDDC/GRE.
Sanatela Matrix Featured on CBS
The company was featured on CBS highlighting its innovative matrix technology for cancer and regenerative medicine.
New Drug Screening Tool for Cancer Research Comes to Market
Sanatela announced the development of a revolutionary platform for precision cancer drug screening using the bioengineered matrix.
How can we use the Matrix to treat cancer?
The article discusses how culturing patient’s cells in the Matrix can help identify effective treatments and move towards personalized cancer therapy.
Why is the Matrix an ideal environment to screen cancer treatments?
The article explains the properties of the Matrix that mimic the natural human microenvironment, enabling more accurate in vitro testing of cancer treatments.
How do you use the Matrix to screen cancer treatments?
The article describes the process of growing cancer cells in the Matrix and testing various treatments to evaluate their effectiveness.
Upcoming Events – Fall 2019
Sanatela Medical will attend various conferences including Resi Conference, CNY Biotech Accelerator, NYS Innovation Summit, Medtech 2019, Start Up Summit, and RDDC/GRE.
Sanatela Matrix Featured on CBS
The company was featured on CBS highlighting its innovative matrix technology for cancer and regenerative medicine.
New Drug Screening Tool for Cancer Research Comes to Market
Sanatela announced the development of a revolutionary platform for precision cancer drug screening using the bioengineered matrix.
How can we use the Matrix to treat cancer?
The article discusses how culturing patient’s cells in the Matrix can help identify effective treatments and move towards personalized cancer therapy.
Why is the Matrix an ideal environment to screen cancer treatments?
The article explains the properties of the Matrix that mimic the natural human microenvironment, enabling more accurate in vitro testing of cancer treatments.
How do you use the Matrix to screen cancer treatments?
The article describes the process of growing cancer cells in the Matrix and testing various treatments to evaluate their effectiveness.